What is RMS’s mission?

The mission of Regenerative Medical Solutions is to develop an affordable, scalable, and ethically grounded prospective functional cure for diabetes through regenerative medicine. RMS aims to translate decades of academic stem cell research into a real-world therapeutic that restores natural insulin production in patients with Type 1 and Type 2 diabetes, without the need for donor organs, chronic immunosuppressive drugs, or implantable devices.

Underpinning this mission is a commitment to scientific rigor, ethical innovation, and long-term patient impact. RMS does not use embryonic stem cells in its work, and its therapy is being designed to be accessible to the widest possible patient population, across all blood types, and potentially applicable to both major forms of diabetes.

Beyond its therapeutic program, RMS supports the broader diabetes research community through its ILC Cell Kit and ProgenMix™ research products, and offers biotech consulting services to organizations working in stem cell biology and regenerative medicine. The company’s ultimate goal is to play a defining role in transforming diabetes from a lifelong condition managed by daily medication into one that can be genuinely cured.

Read more about RMS and our approach to regenerative medicine.